Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

BACKGROUND: Safety and efficacy of botulinum toxin A for glabellar line (GL) treatment are well established. Currently approved formulations require reconstitution before injection. OBJECTIVES: The authors sought to assess 6-month efficacy, safety, and patient satisfaction of new ready-to-use abobot...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascher, Benjamin, Rzany, Berthold, Kestemont, Philippe, Hilton, Said, Heckmann, Marc, Bodokh, Isaac, Noah, Ernst Magnus, Boineau, Dominique, Kerscher, Martina, Volteau, Magali, Le Berre, Philippe, Picaut, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Cosmetic Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923737/
https://www.ncbi.nlm.nih.gov/pubmed/30893430
http://dx.doi.org/10.1093/asj/sjz003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923737/
https://www.ncbi.nlm.nih.gov/pubmed/30893430
http://dx.doi.org/10.1093/asj/sjz003

Ejemplares similares